Dr. Sébastien Ribault

Dr Sébastien Ribault joined Oxford Biomedica in 2022 as Chief Commercial Officer. He has over 25 years of experience across the biotechnology industry and CDMO space. Sébastien was previously at Merck Life Sciences where he was Vice President & Head of Biologics and Viral Vector CDMO, leading Merck’s CDMO Expansion project, establishing the Services business case and helping to establish the Life Science Services business unit. Prior to his 17 years with Merck KGaA, Sébastien was a Gene Therapy Development Scientist at Transgene and Head of the R&D Laboratory at Hemosystem. He has a PhD in Molecular and Cellular Biology from the University of Strasbourg.